Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses?

Creative Commons License

Bölükbaş M. K., Karaca S.

STRAHLENTHERAPIE UND ONKOLOGIE, cilt.196, sa.9, ss.805-812, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 196 Sayı: 9
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1007/s00066-020-01581-4
  • Dergi Adı: STRAHLENTHERAPIE UND ONKOLOGIE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.805-812
  • Anahtar Kelimeler: Esophageal cancer neoplasms, Normal tissue sparing, Dosimetric effects, Helical TomoTherapy, Dose-volume parameters, INTENSITY-MODULATED RADIOTHERAPY, SIMULTANEOUS INTEGRATED BOOST, CONFORMAL RADIOTHERAPY, RADIATION-THERAPY, ARC RADIOTHERAPY, TOMOTHERAPY, IMRT, TOXICITY, OUTCOMES, BEAMS
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose The dose received by the lungs in radiotherapy (RT) is affected by the patient's current lung volume. The presence of predictive factors and cut-off points were investigated to achieve acceptable lung doses in esophageal cancer (EC) treatment. Methods Virtual RT volumes of supracarinal EC were delineated. RT plans were designed with standard criteria in the TomoTherapy planning system (TomoTherapy Inc., Madison, WI, USA). The total dose was 50.4 Gy (1.8 Gy/fraction). ROC (Receiver operating characteristic) analysis and Mann-Whitney U tests were performed. Results There was a total of 65 patient plans included. ROC analysis showed that lung/PTV (Planning target volume) volume ratio (AUC [Area under curve]: 0.91, 95% CI: 0.83-0.99, p = 0.000) and bilateral lung volume (AUC: 0.81, 95% CI: 0.70-0.92, p = 0.000) have diagnostic power to predict the suitability of RT plans according to QUANTEC (Quantitative Analyses of Normal Tissue Effects in the Clinic) for lung dose constraints. The cut-off points of 7 and 3500 cc were selected for lung/PTV ratio and bilateral lung volume, respectively. The effect of the cut-off points on the dose data was assessed with the Mann-Whitney U test. The mean lung and heart doses, lung V5, V15, and V20, as well as heart V5, V20, V30, and V45 values were found to be lower in both groups separated by cut-off points (p < 0.05). Conclusion The lung/PTV ratio >= 7 and bilateral lung volume >= 3500 cc cut-off points are predictive of whether TomoTherapy plans may meet QUANTEC lung dose limits in patients with supracarinal esophageal cancer. The patients with lung/PTV ratio and lung volume above these cut-off points may be candidates for treatment with TomoTherapy.